At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from Istituto Europeo di Oncologia, Milan, Italy, provides an overview of the challenges in the clinical development of precision medicine, which is defined as treatment selection that is guided by specific molecular aberrations in a patient’s tumour, for patients with breast cancer.
Precision medicine for breast cancer
14th June 2016
Oncology
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given